Two Sigma Securities »

Brainstorm Cell Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $35k 102k 0.34
2023-09-30 $8.1k 40k 0.20

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices (AMD)
Microsoft Corporation Call Option (MSFT)
Intel Corporation Call Option (INTC)
Eli Lilly & Co. Call Option (LLY)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Palo Alto Networks Call Option (PANW)
Chevron Corporation Call Option (CVX)
Amazon (AMZN)
Costco Wholesale Corporation Call Option (COST)

View all positions for Two Sigma Securities

Top funds holding Brainstorm Cell Therapeutics

Armistice Capital
Vanguard Group
Geode Capital Management
BlackRock
Liberty Wealth Management
Weaver Consulting Group
Caldwell Sutter Capital
Susquehanna International
Abner, Herrman & BrocK
State Street Corporation
Raymond James & Associates
Two Sigma Securities
Ikarian Capital
Tower Research Capital
Jmac Enterprises

View all funds holding Brainstorm Cell Therapeutics